Interest in advance provision of abortion pills: a national survey of potential users in the USA

被引:6
作者
Lerma, Klaira [1 ,3 ]
Blumenthal, Paul D. [2 ]
机构
[1] Univ Texas Austin, Populat Res Ctr, Austin, TX USA
[2] Stanford Univ, Dept Obstet & Gynecol, Div Family Planning Serv & Res, Stanford, CA USA
[3] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA
关键词
abortion; induced; surveys and questionnaires; Reproductive Rights; Mifepristone; Patient Preference; HEALTH;
D O I
10.1136/bmjsrh-2022-201775
中图分类号
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
1204 ;
摘要
ObjectiveTo assess interest in clinician-administered advance provision of abortion pills among potential users in the USA. MethodsUsing social media advertisements, we recruited people living in the USA who were aged 18-45 years and assigned female at birth, who were not pregnant or planning pregnancy, for an online survey on reproductive health experiences and attitudes. We explored interest in advance provision of abortion pills, participant characteristics, including demographics and pregnancy history, contraceptive use, abortion knowledge and comfort, and healthcare system distrust. We used descriptive statistics to assess interest in advance provision, and ordinal regression modelling to evaluate differences in interest controlling for age, pregnancy history, contraceptive use, familiarity and comfort with medication abortion, and healthcare system distrust, reporting adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs). ResultsFrom January-February 2022, we recruited 634 diverse respondents from 48 states, among whom 65% were interested, 12% neutral, and 23% disinterested in advance provision. There were no differences among interest groups by US region, race/ethnicity, or income. In the model, variables associated with interest included being aged 18-24 years (aOR 1.9, 95% CI 1.0 to 3.4) versus 35-45 years, using a tier 1 (permanent or long-acting reversible) or tier 2 (short-acting hormonal) contraceptive method (aOR 2.3, 95% CI 1.2 to 4.1, and aOR 2.2, 95% CI 1.2 to 3.9, respectively) versus no contraception, being familiar or comfortable with the medication abortion process (aOR 4.2, 95% CI 2.8 to 6.2, and aOR 17.1, 95% CI 10.0 to 29.0, respectively), and having high healthcare system distrust (aOR 2.2, 95% CI 1.0 to 4.4) versus low distrust. ConclusionAs abortion access becomes more constrained, strategies are needed to ensure timely access. Advance provision is of interest to the majority of those surveyed and warrants further policy and logistical exploration.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 23 条
[1]   Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: A population based study [J].
Aiken, Abigail R. A. ;
Romanova, Evdokia P. ;
Morber, Julia R. ;
Gomperts, Rebecca .
LANCET REGIONAL HEALTH-AMERICAS, 2022, 10
[2]  
Barnum Matt, 2022, Chalkbeat
[3]   Cross-state travel for abortion care [J].
Bearak, Jonathan Marc ;
Jones, Rachel K. .
LANCET REGIONAL HEALTH-AMERICAS, 2022, 10
[4]   Support for and interest in alternative models of medication abortion provision among a national probability sample of US women [J].
Biggs, M. Antonia ;
Ralph, Lauren ;
Raifman, Sarah ;
Foster, Diana G. ;
Grossman, Daniel .
CONTRACEPTION, 2019, 99 (02) :118-124
[5]   Confidentiality in Family Planning Services for Young People A Systematic Review [J].
Brittain, Anna W. ;
Williams, Jessica R. ;
Zapata, Lauren B. ;
Moskosky, Susan B. ;
Weik, Tasmeen S. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 49 (02) :S85-S92
[6]  
Center for Reproductive Rights, 2022, ROE FELL AB LAWS STA
[7]  
Department of Health and Human Services, 2021, US FED POV GUID US D
[8]  
Donovan MK., 2018, SELF MANAGED MED ABO
[9]   Making the case for advance provision of mifepristone and misoprostol for abortion in the United States [J].
Ehrenreich, Katherine ;
Biggs, M. Antonia ;
Grossman, Daniel .
BMJ SEXUAL & REPRODUCTIVE HEALTH, 2022, 48 (04) :238-242
[10]  
Jones R. K., 2022, Medication abortion now accounts for more than half of all US abortions